1. Horizon 2020: European perspectives in healthcare sciences and implementation

   • Irene Norstedt

   Meeting abstract Open access 11 February 2014 Article: A1

2. Political regulations to advance health care system

   • Olga Golubnitschaja

   Meeting abstract Open access 11 February 2014 Article: A2

3. Time for new guidelines in personalised healthcare: PPPM related legislation

   • Olga Golubnitschaja
   • Vincenzo Costigliola

   Meeting abstract Open access 11 February 2014 Article: A3

   

4. Global strategies for non-communicable disease in terms of predictive, preventive and personalised medicine

   • Hiroyasu Iso
   • Yoshihiro Kokubo

   Meeting abstract Open access 11 February 2014 Article: A4

5. EuroBioForum - the gateway to partnering in Europe

   • Wouter Spek

   Meeting abstract Open access 11 February 2014 Article: A5

6. The FDA initiatives for personalized medicine

   • Olive Joy Wolfe

   Meeting abstract Open access 11 February 2014 Article: A6

7. Corporate medicine is usurping the doctor-patient relationship in America

   • Russell J Andrews

   Meeting abstract Open access 11 February 2014 Article: A7

8. Legislative initiatives can speed PPPM innovation in medicine

   • Trevor G Marshall

   Meeting abstract Open access 11 February 2014 Article: A8

9. PPPM health care - United States style: political, profitable, and profligate medicine

   • Russell J Andrews

   Meeting abstract Open access 11 February 2014 Article: A9

10. Work in progress, developing of guidelines - How could EPMA contribute to better health care in developing countries

    • Anna Benini

    Meeting abstract Open access 11 February 2014 Article: A10

11. Boosting drug development through public-private partnerships – The IMI model

    • Hugh Laverty

    Meeting abstract Open access 11 February 2014 Article: A11

12. Professional education in PPPM as the realistic platform for the medicine of the future: EPMA takes action

    • Olga Golubnitschaja

    Meeting abstract Open access 11 February 2014 Article: A12

    

13. Healthcare overview: new perspectives

    • Vincenzo Costigliola

    Meeting abstract Open access 11 February 2014 Article: A13

    

14. New strategies to advance pre/diabetes care: integrative approach by PPPM

    • Mahmood S Mozaffari

    Meeting abstract Open access 11 February 2014 Article: A14

15. Drug delivery systems: advanced technologies potentially applicable in personalised treatment, educational measures

    • Jorge FJ Coelho

    Meeting abstract Open access 11 February 2014 Article: A15

16. A new book “Rare Diseases: Integrative PPPM Approach as the Medicine of the Future”

    • Meral Özgüç

    Meeting abstract Open access 11 February 2014 Article: A16

17. Individualized medicine – ethical, economical and historical perspectives

    • Tobias Fischer
    • Martin Langanke
    • Susanne Michl

    Meeting abstract Open access 11 February 2014 Article: A17

18. Predictive, preventive, personalised and participatory periodontology: State of knowledge and future perspectives

    • Carlo Cafiero

    Meeting abstract Open access 11 February 2014 Article: A18

19. Education in personalized medicine in Czech Republic

    • Marie Karlikova
    • Ondrej Topolcan
    • Radka Fuchsova

    Meeting abstract Open access 11 February 2014 Article: A19

20. New international education project in predictive, preventive and personalized medicine

    • Olga Safonicheva

    Meeting abstract Open access 11 February 2014 Article: A20

21. The activities of the young professionals EPMA in the Czech Republic

    • Jiri Polivka Jr
    • Pavla Sadilkova
    • Jiri Polivka

    Meeting abstract Open access 11 February 2014 Article: A21

22. The Alexander von Humboldt-Foundation

    • Alexander von Humboldt-Stiftung

    Meeting abstract Open access 11 February 2014 Article: A22

23. Personalised treatment for cancer: role of biomarkers

    • Michael J Duffy

    Meeting abstract Open access 11 February 2014 Article: A23

24. A clinical pharmacogenetic characterization of DPD polymorphisms for pre-treatment screening of patients candidates to fluoropyrimidine therapy

    • Marzia Del Re
    • Fotios Loupakis
    • Romano Danesi

    Meeting abstract Open access 11 February 2014 Article: A24

25. Multi-parameter systematic strategy opinion that predicts, prevents, and personalized treats a cancer

    • Xianquan Zhan
    • Rong Hu
    • Xiaowei Wang

    Meeting abstract Open access 11 February 2014 Article: A25

26. Predictive markers in cancer patient diagnosis, classification and prediction of therapy outcome using leukaemia as a model

    • Godfrey Grech
    • Shawn Baldacchino
    • Anthony Fenech

    Meeting abstract Open access 11 February 2014 Article: A26

27. Relevance of ERCC1, RRM1 and BRCA1 in surgically treated non-small cell lung cancer patients

    • Martin Pesta
    • Ondrej Topolcan
    • Milos Pesek

    Meeting abstract Open access 11 February 2014 Article: A27

28. Genome-proteome system for prostate cancer

    • Maxim N Peshkov

    Meeting abstract Open access 11 February 2014 Article: A28

29. Frequency of the DPYD * 2A allele in the Czech population

    • Monika Koudová
    • Martina Bittóová
    • Lucie Pavlíčková

    Meeting abstract Open access 11 February 2014 Article: A29

    

30. Pitfalls and perspectives in cancer genomes NGS studies: implications for predictive, preventive and personalized medicine (PPPM)

    • Ugo Rovigatti

    Meeting abstract Open access 11 February 2014 Article: A30

31. The application of personalized medicine in neurooncology

    • Jiri Polivka Jr
    • Jiri Polivka
    • Ondrej Topolcan

    Meeting abstract Open access 11 February 2014 Article: A31

32. Comparing ion torrent with pyrosequencing and Sanger sequencing for the detection of TP53 mutations in colorectal cancer

    • Brendan Doyle
    • Clarence C Lee
    • Orla Sheils

    Meeting abstract Open access 11 February 2014 Article: A32

33. Novel approaches such as pharmacogenetics and liquid biopsies in tumor treatment in the era of personalized therapy

    • Milena Kralickova
    • Vaclav Liska
    • Pavel Soucek

    Meeting abstract Open access 11 February 2014 Article: A33

34. Possibilities for preventive and personalized therapy of cancer by drugs screening

    • Igor V Volchek
    • Tamara V Sologub
    • Andrei S Petrov

    Meeting abstract Open access 11 February 2014 Article: A34

35. Preventive regimen of immunostimulants within personalised “3S” paradigm of anticancer drug testing

    • Ekaterina Moiseeva

    Meeting abstract Open access 11 February 2014 Article: A35

36. Prognostic value of tumor markers in malignant melanoma

    • Inka Treskova
    • Jindra Vrzalova
    • Vladislav Treska

    Meeting abstract Open access 11 February 2014 Article: A36

37. Serum levels of markers in early detection of prostate cancer (pilote study)

    • Radka Fuchsova
    • Ondrej Topolcan
    • Jiri Ferda

    Meeting abstract Open access 11 February 2014 Article: A37

    

38. “Molecular signature” in blood of liver cancer diagnosed patients as a criterion for optimal therapy modalities

    • Olga Golubnitschaja
    • Melanie Cebioglu
    • Hans H Schild

    Meeting abstract Open access 11 February 2014 Article: A38

    

39. Assessment of endometrial receptor systems for PPPM approach for endometrial hyperplasia in reproductive age women

    • Vadym M Goncharenko
    • Vasyl A Beniuk
    • Rostyslav V Bubnov

    Meeting abstract Open access 11 February 2014 Article: A39

40. Personalized treatment strategy for atypical endometrial hyperplasia with regards to age, comorbidities and endometrial receptor status

    • Vadym M Goncharenko
    • Vasyl A Beniuk
    • Rostyslav V Bubnov

    Meeting abstract Open access 11 February 2014 Article: A40

41. Challenges in breast cancer management and prevention

    • Manuel Debald
    • Walther Kuhn
    • Olga Golubnitschaja

    Meeting abstract Open access 11 February 2014 Article: A41

42. Detection of KRAS mutant alleles in circulating cell-free tumor DNA in colorectal cancer patients resistant to cetuximab

    • Marzia Del Re
    • Paola Ulivi
    • Dino Amadori

    Meeting abstract Open access 11 February 2014 Article: A42

43. Hepatic oncology diagnosis based on imaging fractal analysis: preliminary results

    • Rostyslav V Bubnov
    • Ivan M Melnyk

    Meeting abstract Open access 11 February 2014 Article: A43

44. Personalized cancer care through biology informed treatment decisions

    • Peter Kuhn

    Meeting abstract Open access 11 February 2014 Article: A44

45. CD133-regulated nucleophosmin expression in human colon cancer cells

    • Kun Kim
    • Kyung-Hee Kim
    • Ja-Lok Ku

    Meeting abstract Open access 11 February 2014 Article: A45

46. Mechanism of anti-tumor and anti-invasive function of SOCS isoform in colon cancer models

    • Won Ki Kim
    • ji-Yoon Ryu
    • Choong-Eun Lee

    Meeting abstract Open access 11 February 2014 Article: A46

47. HSP27 phosphorylation inhibitor regulates Her2 expression in human breast cancer cell line SK-BR-3 with induced Herceptin resistance

    • Min Kyung Kim
    • Seung Cheol Kim
    • Byong Chul Yoo

    Meeting abstract Open access 11 February 2014 Article: A47

48. Concept of molecular prevention

    • Christoph A Karle
    • Giang Duong
    • Thomas M Helms

    Meeting abstract Open access 11 February 2014 Article: A48

    

49. From integrative disease modeling to predictive, preventive, personalized and participatory (P4) medicine

    • Erfan Younesi
    • Martin Hofmann-Apitius

    Meeting abstract Open access 11 February 2014 Article: A49

50. The role of informatics in the shift from reactive to proactive healthcare

    • Michael Legg

    Meeting abstract Open access 11 February 2014 Article: A50